Delivery Order SPE2DB20D3304-SPE2DB25FW6S5

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565504053 - Ondansetron ODT 8 MG Tablet 30s. The contract has a firm fixed price of $6,694.51 and an ultimate completion date of August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,469,416 units of the prescription drug Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $1,735.60 and a period of performance through August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093,137 units of Ondansetron ODT 4 mg tablets, with a firm fixed price ceiling value of $2,158.78. The contract has an ultimate completion date of May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,007,214 units of the drug Ondansetron ODT 8 mg tablets. The contract is a firm-fixed-price delivery order valued at $3,591.00 with a period of performance through January 23, 2025. The contract was not designated as a set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,236 units of the medication Ondansetron ODT 8 mg tablet. The contract has a firm-fixed price of $4,042.19 and a performance period extending through May 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,146,781 units of the prescription medication Ondansetron ODT 8 mg tablet in 30-count packages. The contract has a firm fixed price and a ceiling value of $10,244.47. It is not set aside for any special type of business. The contract has an ultimate completion date of May 6,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,206,756 units of the medication Ondansetron ODT 4 mg tablet in quantities of 30 per package. The contract has a ceiling value of $13,890.74 and is a firm fixed-price delivery order, with a period of performance through May 12, 2025. The contract is not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,152.18, is for the supply of Ondansetron ODT 8 mg tablets to support military healthcare programs. The contract type is Firm Fixed Price, and the ultimate completion date is February 7, 2025. This order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ondansetron ODT 8 mg tablets. The contract has a firm fixed price and a ceiling value of $5,663.85. The period of performance extends through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500 doses of the medication Ondansetron ODT 8 mg Tablet, with a ceiling value of $1,400.16 and a period of performance through January 27, 2025. The contract is a firm fixed-price, delivery order contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW6S5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568183306 - Ondansetron ODT 8 mg Tablet 30s. The contract has a firm fixed price of $2,001.16 and a performance period ending on May 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/10/25, 1:02 AM